title: Long-term effects of ATG therapy on lymphocyte subsets.
authors.affiliation: Nephrology and Transplant Department, Hospital de Santo António, Porto, Portugal.
authors.forename: L
authors.initials: L
authors.lastname: Martins
authors.forename: A
authors.initials: A
authors.lastname: Ventura
authors.forename: L
authors.initials: L
authors.lastname: Dias
authors.forename: A
authors.initials: A
authors.lastname: Henriques
authors.forename: A
authors.initials: A
authors.lastname: Sarmento
authors.forename: S
authors.initials: S
authors.lastname: Guimarães
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D017252:CD3 Complex / Q000097:blood; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D018655:Lymphocyte Count; D016131:Lymphocyte Subsets / Q000187:drug effects* / Q000276:immunology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012016:Reference Values; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D017252:CD3 Complex; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D008775:Methylprednisolone